133 related articles for article (PubMed ID: 7925203)
1. Early and late reversibility of rocuronium bromide.
van den Broek L; Proost JH; Wierda JM
Eur J Anaesthesiol Suppl; 1994; 9():128-32. PubMed ID: 7925203
[TBL] [Abstract][Full Text] [Related]
2. Neuromuscular and cardiovascular effects of neostigmine and methyl-atropine administered at different degrees of rocuronium-induced neuromuscular block.
Van den Broek L; Proost JH; Wierda JM; Njoo MD; Hennis PJ
Eur J Anaesthesiol; 1994 Nov; 11(6):481-7. PubMed ID: 7851356
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of neuromuscular effects and antagonism of rocuronium bromide: a preliminary report.
Davis L; Jayarajah MJ; Toner CC; Flynn PJ
Eur J Anaesthesiol Suppl; 1995 Sep; 11():65-8. PubMed ID: 8557009
[TBL] [Abstract][Full Text] [Related]
4. Dose-response relationships for neostigmine antagonism of rocuronium-induced neuromuscular block in children and adults.
Abdulatif M; Mowafi H; al-Ghamdi A; el-Sanabary M
Br J Anaesth; 1996 Dec; 77(6):710-5. PubMed ID: 9014620
[TBL] [Abstract][Full Text] [Related]
5. Neostigmine injected 5 minutes after low-dose rocuronium accelerates the recovery of neuromuscular function.
Lederer W; Reiner T; Khuenl-Brady KS
J Clin Anesth; 2010 Sep; 22(6):420-4. PubMed ID: 20868962
[TBL] [Abstract][Full Text] [Related]
6. Dose-response relationships for edrophonium and neostigmine antagonism of rocuronium bromide (ORG 9426)-induced neuromuscular blockade.
Naguib M; Abdulatif M; al-Ghamdi A
Anesthesiology; 1993 Oct; 79(4):739-45. PubMed ID: 8214753
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacology of rocuronium (Org 9426): study of the time course of action, dose requirement, reversibility, and pharmacokinetics.
van den Broek L; Wierda JM; Smeulers NJ; van Santen GJ; Leclercq MG; Hennis PJ
J Clin Anesth; 1994; 6(4):288-96. PubMed ID: 7946364
[TBL] [Abstract][Full Text] [Related]
8. Dose-response relationship of rocuronium bromide during intravenous anaesthesia.
Mellinghoff H; Diefenbach C; Bischoff A; Grond S; Buzello W
Eur J Anaesthesiol Suppl; 1994; 9():20-4. PubMed ID: 7925204
[TBL] [Abstract][Full Text] [Related]
9. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
Sacan O; White PF; Tufanogullari B; Klein K
Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
[TBL] [Abstract][Full Text] [Related]
10. Delayed reversal of a potentiated rocuronium neuromuscular block.
Dubois PE
Eur J Anaesthesiol; 2009 Apr; 26(4):350-2. PubMed ID: 19401670
[No Abstract] [Full Text] [Related]
11. The effect of residual neuromuscular blockade on the speed of reversal with sugammadex.
White PF; Tufanogullari B; Sacan O; Pavlin EG; Viegas OJ; Minkowitz HS; Hudson ME
Anesth Analg; 2009 Mar; 108(3):846-51. PubMed ID: 19224792
[TBL] [Abstract][Full Text] [Related]
12. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
[TBL] [Abstract][Full Text] [Related]
13. Optimum dose of neostigmine to reverse shallow neuromuscular blockade with rocuronium and cisatracurium.
Choi ES; Oh AY; Seo KS; Hwang JW; Ryu JH; Koo BW; Kim BG
Anaesthesia; 2016 Apr; 71(4):443-9. PubMed ID: 26874258
[TBL] [Abstract][Full Text] [Related]
14. Optimum time for neostigmine administration to antagonize vecuronium-induced neuromuscular blockade.
Kirkegaard-Nielsen H; Toft P; Severinsen IK; May O
Eur J Anaesthesiol; 1995 Nov; 12(6):585-9. PubMed ID: 8665881
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous or neostigmine-induced recovery after maintenance of neuromuscular block with Org 9487 (rapacuronium) or rocuronium following an initial dose of Org 9487.
McCourt KC; Mirakhur RK; Lowry DW; Carroll MT; Sparr HJ
Br J Anaesth; 1999 May; 82(5):755-6. PubMed ID: 10536556
[TBL] [Abstract][Full Text] [Related]
16. Chemical encapsulation of rocuronium by synthetic cyclodextrin derivatives: reversal of neuromuscular block in anaesthetized Rhesus monkeys.
de Boer HD; van Egmond J; van de Pol F; Bom A; Booij LH
Br J Anaesth; 2006 Feb; 96(2):201-6. PubMed ID: 16377646
[TBL] [Abstract][Full Text] [Related]
17. Clinical study of interaction between rocuronium and some commonly used antimicrobial agents.
Cooper R; Maddineni VR; Mirakhur RK
Eur J Anaesthesiol; 1993 Sep; 10(5):331-5. PubMed ID: 11767421
[TBL] [Abstract][Full Text] [Related]
18. Is neuromuscular relaxation of rocuronium prolonged in patients with obstructive jaundice?
Wang Z; Bao Y; Lu Z; Yu W
Med Hypotheses; 2011 Jan; 76(1):100-1. PubMed ID: 20832951
[TBL] [Abstract][Full Text] [Related]
19. Recovery of neuromuscular function after a combination of mivacurium and rocuronium.
Stout RG; Shine TS; Silverman DG; Brull SJ
Yale J Biol Med; 2004 Sep; 77(5-6):149-54. PubMed ID: 15989744
[TBL] [Abstract][Full Text] [Related]
20. Time course of action and recovery of rocuronium bromide in children during halothane anaesthesia--a preliminary report.
Motsch J; Leuwer M; Pfau M; Zimmerman J; Martin E
Eur J Anaesthesiol Suppl; 1994; 9():75-7. PubMed ID: 7925213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
